Aura Biosciences, Inc. (AURA) financial statements and ratios from SEC XBRL. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Price / Book | 2.55 |
| FCF Yield | -23.3% |
| Sector P/E (Healthcare) | 21.6 |
AURA overview · AURA earnings · AURA KPIs · AURA investor relations · AURA ownership · AURA peers · AURA filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.